The following information I culled from the Jerusalem Post:
“A new study from George Washington University noted that an aspirin regimen in more than 400 COVID-19 patients in hospitals across the United States cut the need for ventilation by 44 percent, slashed ICU admission by 43 percent, and reduced overall in-hospital mortality rates by 47 percent.”
This article comes directly from today’s New York Times…
“Doctors should no longer routinely begin prescribing a daily regimen of low-dose aspirin to most people at high risk of a first heart attack or stroke, according to new draft guidelines by a U.S. panel of experts.”
It is interesting how what has worked for years (I have been taking a low dose each night before bed ever since my father had a fatal stroke in 1995) no long is recommended, and it comes only a day after another study states aspirin can treat COVID-19.
Leave a comment